Interstitial pulmonary fibrosis with and without associated collagen vascular diseases: results of a two year follow up

dc.contributor.authorAgustí, C.
dc.contributor.authorXaubet Mir, Antonio
dc.contributor.authorAgustí García-Navarro, Àlvar
dc.contributor.authorRoca Torrent, Josep
dc.contributor.authorRodríguez-Roisin, Robert
dc.date.accessioned2022-09-23T18:12:04Z
dc.date.available2022-09-23T18:12:04Z
dc.date.issued1992
dc.date.updated2022-09-23T18:12:04Z
dc.description.abstractBackground: Interstitial pulmonary fibrosis is a disease with a highly variable clinical course. To ascertain if an inadequate selection of patients might explain part of this variability, two different groups of patients with interstitial pulmonary fibrosis, those with the 'lone' form of the disease (LIPF) and those with associated collagen vascular disorders (AIPF), were studied separately. Methods: Twenty consecutive patients (nine with LIPF and 11 with AIPF) were included. Their clinical and radiographic findings and results of pulmonary function tests, gallium-67 lung scanning, and cellular analysis of bronchoalveolar lavage fluid were compared at diagnosis. Moreover, the evolution of LIPF and AIPF was contrasted after a follow up of two years, both groups having received a similar treatment regimen of corticosteroids. Results: At enrollment, patients with LIPF and AIPF were of similar age, and had similar symptoms and derangement of lung function, but patients with LIPF presented with finger clubbing, more obvious radiographic abnormalities, and a greater percentage of eosinophils in bronchoalveolar lavage fluid. Two years later, patients with LIPF had significantly decreased FVC, FEV1, TLC, TLCO, and PaO2. By contrast, lung function remained unaltered in patients with AIPF. Similarly, when the percentage change from entry to the study was compared, patients with LIPF showed a significant decrease in FVC, FEV1, and PaO2. Conclusions: Unlike the patients with AIPF, those with LIPF showed a deterioration in lung function and developed further restrictive impairment and poorer gas exchange. This has implications in their clinical management.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec072278
dc.identifier.issn0040-6376
dc.identifier.urihttps://hdl.handle.net/2445/189310
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1136/thx.47.12.1035
dc.relation.ispartofThorax, 1992, vol. 47, num. 12, p. 1035-1040
dc.relation.urihttps://doi.org/10.1136/thx.47.12.1035
dc.rights(c) BMJ Publishing Group, 1992
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationFibrosi pulmonar
dc.subject.classificationCol·lagenosi
dc.subject.classificationFisiologia patològica
dc.subject.otherPulmonary fibrosis
dc.subject.otherCollagen diseases
dc.subject.otherPathological physiology
dc.titleInterstitial pulmonary fibrosis with and without associated collagen vascular diseases: results of a two year follow up
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
072278.pdf
Mida:
1.04 MB
Format:
Adobe Portable Document Format